company background image
0I7E logo

DaVita LSE:0I7E Stock Report

Last Price

US$134.22

Market Cap

US$11.8b

7D

-1.2%

1Y

75.3%

Updated

24 Mar, 2024

Data

Company Financials +

0I7E Stock Overview

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.

0I7E fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance4/6
Financial Health3/6
Dividends0/6

DaVita Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for DaVita
Historical stock prices
Current Share PriceUS$134.22
52 Week HighUS$141.39
52 Week LowUS$71.57
Beta1.03
1 Month Change7.58%
3 Month Change28.21%
1 Year Change75.30%
3 Year Change25.21%
5 Year Change148.97%
Change since IPO69.68%

Recent News & Updates

Recent updates

Shareholder Returns

0I7EGB HealthcareGB Market
7D-1.2%-0.6%2.3%
1Y75.3%-21.2%4.9%

Return vs Industry: 0I7E exceeded the UK Healthcare industry which returned -21.2% over the past year.

Return vs Market: 0I7E exceeded the UK Market which returned 4.9% over the past year.

Price Volatility

Is 0I7E's price volatile compared to industry and market?
0I7E volatility
0I7E Average Weekly Movement4.1%
Healthcare Industry Average Movement7.7%
Market Average Movement4.7%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.5%

Stable Share Price: 0I7E has not had significant price volatility in the past 3 months.

Volatility Over Time: 0I7E's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199470,000Javier Rodriguezhttps://www.davita.com

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

DaVita Inc. Fundamentals Summary

How do DaVita's earnings and revenue compare to its market cap?
0I7E fundamental statistics
Market capUS$11.76b
Earnings (TTM)US$691.54m
Revenue (TTM)US$12.14b

17.0x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0I7E income statement (TTM)
RevenueUS$12.14b
Cost of RevenueUS$8.32b
Gross ProfitUS$3.82b
Other ExpensesUS$3.13b
EarningsUS$691.54m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)7.89
Gross Margin31.47%
Net Profit Margin5.70%
Debt/Equity Ratio296.6%

How did 0I7E perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.